Patents by Inventor Martin Borre

Martin Borre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6020132
    Abstract: A method for determining a molecule A comprising a sample of molecules capable of participating in formation of triplex structures is useful for sensitive determination. The principle can be used to determine any kind of analytes.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: February 1, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Henrik .O slashed.rum, Troels Koch, Martin Borre, Henrik Frydenlund Hansen
  • Patent number: 5231168
    Abstract: The present invention relates to a polypeptide comprising a characteristic amino acid sequence derived from the Plasmodium falciparum antigen GLURP, a polypeptide which is recognized by an antibody raised against or reactive with a polypeptide comprising said characteristic amino acid sequence and/or an antibody reactive with native GLURP, a nucleic acid molecule (DNA-fragment) encoding said polypeptide, an expression vector carrying the nucleic acid molecule, an organism expressing said nucleic acid molecule so as to produce said polypeptide, a monoclonal antibody directed against said polypeptide, a diagnostic agent comprising said antibody or said polypeptide for use in assaying Plasmodium falciparum infection and thus diagnosing malaria, and the use of said antibody or said polypeptide for therapeutic purposes, e.g. as a component in a vaccine.
    Type: Grant
    Filed: September 18, 1989
    Date of Patent: July 27, 1993
    Assignee: Statens Seruminstitut
    Inventors: Morten Dziegiel, Martin Borre, Soren Jepsen, Jens Vuust, Klaus Rieneck, Annette Wind, Palle H. Jakobsen